₹216.00
+2.86%NSE close, 16 Nov 2026
+273.38%
ACCRETION PHARMA is a small cap company, listed on NSE SME under the symbol ACCPL. At ₹216.00 a share, the market values the whole company at ₹240 crore. NSE SME is the exchange's platform for small and medium companies, which report their results every half year.
In FY26, it reported sales of ₹90 crore and a net profit of ₹10 crore, an operating margin of 16.7%.
The market values the company at 18.3 times its profit over the last twelve months and 3.82 times its book value; its return on equity is 20.9% and its borrowings are 0.27 times its equity.
Promoters hold 73.52% of the shares. Foreign institutions hold 0.17%, and domestic institutions, mutual funds among them, 3.65%.
Over the past year the share price has risen 291.7%, and it is 1.8% below its 52-week high.
Listed on NSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
₹ crore. Standalone figures: the company files no consolidated results.
| Line | 6M to Mar 2025 | 6M to Sep 2025 | 6M to Mar 2026 | 6M to Sep 2026 |
|---|---|---|---|---|
| Sales | 38.8 | 43.7 | 45.9 | 55.0 |
| Expenses | 31.3 | 36.7 | 38.0 | 42.8 |
| Operating profit | 7.5 | 7.1 | 7.9 | 12.2 |
The financial results for the period ended September 30, 2026.
Company Reports 25.83% Revenue Growth and 72.63% PAT Growth in H1 FY27 and Strong EBITDA Growth of 72.28%; EBITDA Margin Improves to 22.48%
The unaudited financial results for the half year ended September 30, 2026.
| Operating margin |
|---|
| 19.4% |
| 16.2% |
| 17.2% |
| 22.2% |
| Other income | 0.1 | 0.1 | 0.1 | 0.2 |
|---|
| Interest | 0.7 | 0.4 | 0.5 | 0.7 |
|---|
| Depreciation | 0.4 | 0.4 | 0.8 | 0.9 |
|---|
| Profit before tax | 6.5 | 6.4 | 6.7 | 10.8 |
|---|
| Tax | 2.1 | 1.7 | 1.8 | 2.6 |
|---|
| Net profit | 4.3 | 4.8 | 4.9 | 8.2 |
|---|
| EPS (₹) | 5.30 | 4.61 | 4.42 | 7.38 |
|---|
₹ crore, financial years to March.
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|
| From operations | 5.8 | −14.6 | −3.1 |
| From investing | −1.6 | −8.5 | −2.5 |
| From financing | −4.3 | 27.1 | 3.8 |
| Spent on fixed assets | −1.6 | −8.5 | −2.5 |
| Free cash flow | 4.2 | −23.2 | −5.7 |
Margins, returns, debt, tax and cash.
| Line | FY25 | FY26 |
|---|---|---|
| Net margin | 11.8% | 10.8% |
| Operating margin | 20.7% | 16.7% |
| Return on equity | 44.4% | 17.7% |
| Return on capital employed | 38.1% | 20.8% |
| Return on assets | 17.0% | 12.6% |
| Debt to equity | 0.92 | 0.23 |
| Interest coverage | 7.80 | 16.40 |
| Debt to assets | 0.35 | 0.16 |
| Current ratio | 1.44 | 2.91 |
| Quick ratio | 0.56 | 1.55 |
| Cash ratio | 0.00 | 0.19 |
| Asset turnover | 1.44 | 1.17 |
| Fixed asset turnover | 9.42 | 6.79 |
| Inventory turnover | 1.90 | 2.30 |
| Receivables turnover | 4.90 | 4.00 |
| Gross margin | 30.4% | 27.3% |
| Cash from operations to profit | 86.0% | -151.0% |
| Effective tax rate | 30.4% | 26.1% |
Proceedings of Postal Ballot. Further, the company has submitted the Exchange a copy of Srutinizers report.
The Amendment to AOA/MOA of the company.
A copy Srutinizers report of Postal Ballot
Proceedings of Postal Ballot
Has informed regarding Submission of the Compliance Report on Non-Applicability of Corporate Governance for the Q2 FY 2026-27.
Notice of Postal Ballot
The Amendment to AOA/MOA of the company.
A copy Srutinizers report of Annual General Meeting held on August 27, 2026
Proceedings of Annual General Meeting held on August 27, 2026